
bit.bio
bit.bio is an award-winning human synthetic biology company whose mission is to code cells for novel cures. They have developed an end-to-end platform for the creation of any human cell type. With their cutting-edge and patent-protected opti-ox™ precision cell programing technology, bit.bio can deterministically program human induced pluripotent stem cells (iPSCs) into a chosen cell identity with unprecedented biological consistency at an industrial scale and approximately 10 times faster than conventional methods. Their platform has the potential to unlock a new generation of medicines.
Latest bit.bio Content

Speeding Up Neuroscience Research

Precision Reprogrammed iPSC Models for High-Throughput Drug Discovery

Uncovering the Glioma Microenvironment With In Vitro Neuronal Models

Innovations in Disease Modeling 2024

The Pathology of Proteins: A Tangled Tale of Alzheimer's

Revolutionizing In Vitro Disease Models With iPSC Reprogramming Technology

Precision Reprogramming iPSCs To Generate a Source of Defined, Scalable Human Cells

Discover a New Approach to Modeling Neurodegeneration

Optimized Human iPSC-Derived Sensory Neurons for Pain and Neuropathy Research
